Transient Efficacy of Double High-Dose Chemotherapy and Autologous Peripheral Stem Cell Transplantation, Immunoglobulin, Thalidomide, and Bortezomib in the Treatment of Scleromyxedema-Reference-Cited by-同舟云学术

Transient Efficacy of Double High-Dose Chemotherapy and Autologous Peripheral Stem Cell Transplantation, Immunoglobulin, Thalidomide, and Bortezomib in the Treatment of Scleromyxedema

Published:2008 Issue:4 Volume:9 Page:271-273
ISSN:1175-0561
Container-title:American Journal of Clinical Dermatology
language:en
Short-container-title:American Journal of Clinical Dermatology

Author:

Ataergin Selmin,Arpaci Fikret,Demiriz Murat,Ozet Ahmet

Publisher

Springer Science and Business Media LLC

Subject

Dermatology,General Medicine

Reference6 articles.

1. Successful Treatment of Scleromyxedema With Autologous Peripheral Blood Stem Cell Transplantation

2. Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation

3. Steady remission of scleromyxedema 3 years after autologous stem cell transplantation: an in vivo and in vitro study

4. Final Report of Toxicity and Efficacy of a Phase II Study of Oral Cyclophosphamide, Thalidomide, and Prednisone for Patients with Relapsed or Refractory Multiple Myeloma: A Hoosier Oncology Group Trial, HEM01-21

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dermato-neuro Syndrome after COVID-19 Vaccination in a Patient with Scleromyxoedema Previously Controlled with Bortezomib and Intravenous Immunoglobulins;Acta Dermato-Venereologica;2022-12-13

2. Scleromyxedema;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2020-12

3. Skleromyxödem;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2020-12

4. Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literature;Clinical Case Reports;2020-09-17

5. Scleromyxedema treatment: a systematic review and update;International Journal of Dermatology;2020-05-02